Gefjon Pharma is a company headquartered in Denmark.
Gefjon Pharma develops innovative OMV-based vaccine technology, including a broad-spectrum aerosol E. coli vaccine for poultry, aiming to provide scalable, cost-effective biologics for veterinary and human medicine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.